Prajwal Dhakal Selected Research

Prajwal Dhakal Research Topics

8	Neoplasms (Cancer) 01/2022 - 12/2014
5	Hemorrhage 01/2020 - 10/2015
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 01/2020
3	Thrombocytopenia (Thrombopenia) 01/2017 - 01/2015
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2022 - 01/2020
2	Pulmonary Embolism 08/2019 - 01/2019
2	Infections 10/2017 - 01/2017
1	Pain (Aches) 01/2022
1	Acute Promyelocytic Leukemia 01/2022
1	Body Weight (Weight, Body) 01/2020
1	Adenocarcinoma 08/2019
1	Anaphylaxis (Anaphylactic Shock) 08/2019
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2019
1	Factor VII Deficiency (Hypoproconvertinemia) 01/2018
1	Mycoses (Diseases, Fungus) 10/2017
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2017
1	Thrombosis (Thrombus) 09/2017
1	Renal Insufficiency (Renal Failure) 09/2017
1	Thrombotic Microangiopathies 03/2017
1	Liver Diseases (Liver Disease) 01/2017
1	Hypersplenism (Anemia, Splenic) 01/2017
1	Opportunistic Infections (Opportunistic Infection) 01/2016
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2016
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2014
1	Hamartoma 12/2014
1	Tuberous Sclerosis (Bourneville's Disease) 12/2014
1	Autosomal Dominant Polycystic Kidney (ADPKD) 12/2014
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 12/2014
1	Aortic Dissection 11/2014

3	AnticoagulantsIBA 09/2017 - 01/2015
2	Vitamin K FDA Link 09/2017 - 07/2017
2	RivaroxabanIBA 09/2017 - 01/2015
2	Dabigatran FDA Link 09/2017 - 01/2015
2	Heparin (Liquaemin)FDA LinkGeneric 10/2015 - 01/2015
1	venetoclaxIBA 01/2021
1	tisagenlecleucelIBA 01/2020
1	N(4)-oleylcytosine arabinosideIBA 01/2020
1	blinatumomabIBA 01/2020
1	Inotuzumab OzogamicinIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Hemostatics (Antihemorrhagics)IBA 01/2020
1	Rituximab (Mabthera)FDA Link 10/2019
1	Inosine Triphosphate (ITP)IBA 10/2019
1	Intravenous Immunoglobulins (IVIG)FDA Link 10/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2019
1	Pemetrexed (MTA)FDA Link 08/2019
1	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 08/2019
1	factor VII clotting antigenIBA 01/2018
1	idarucizumabIBA 09/2017
1	apixabanIBA 09/2017
1	PRT064445IBA 09/2017
1	Prothrombin (Factor II)IBA 07/2017
1	Warfarin (Coumadin)FDA LinkGeneric 07/2017
1	Tacrolimus (Prograf)FDA LinkGeneric 03/2017
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2017
1	eculizumab FDA Link 03/2017
1	romiplostim FDA Link 01/2017
1	Erythropoietin FDA Link 01/2017
1	Danazol (Azol)FDA LinkGeneric 01/2017
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2017
1	Thrombopoietin (c-mpl Ligand)IBA 01/2017
1	Antiviral Agents (Antivirals)IBA 01/2017
1	avatrombopagIBA 01/2017
1	eltrombopag FDA Link 01/2017
1	Interleukin-11 (Interleukin 11)IBA 01/2017
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2016
1	Calcineurin InhibitorsIBA 01/2016
1	trans-sodium crocetinate (crocetin)IBA 12/2014

8	Therapeutics 01/2022 - 10/2015
3	Drug Therapy (Chemotherapy) 10/2022 - 10/2017
2	Length of Stay 01/2022 - 01/2019
2	Anticoagulation Reversal 01/2020 - 07/2017
1	Polypharmacy 01/2020
1	Operative Surgical Procedures 01/2020
1	Catheters 09/2017
1	Plasma Exchange 03/2017
1	Percutaneous Coronary Intervention 11/2014